David R. Liu - Net Worth and Insider Trading
David R. Liu Net Worth
The estimated net worth of David R. Liu is at least $88 Million dollars as of 2025-07-24. David R. Liu is the 10% Owner of Prime Medicine Inc and owns about 20,240,945 shares of Prime Medicine Inc (PRME) stock worth over $88 Million. Details can be seen in David R. Liu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R. Liu has not made any transactions after 2025-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David R. Liu
David R. Liu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R. Liu owns 2 companies in total, including Editas Medicine Inc (EDIT) , and Prime Medicine Inc (PRME) .
Click here to see the complete history of David R. Liu’s form 4 insider trades.
Insider Ownership Summary of David R. Liu
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| EDIT | Editas Medicine Inc | 2016-02-02 | 10 percent owner |
| PRME | Prime Medicine Inc | 2025-06-30 | 10 percent owner |
David R. Liu Latest Holdings Summary
David R. Liu currently owns a total of 1 stock. David R. Liu owns 20,240,945 shares of Prime Medicine Inc (PRME) as of June 30, 2025, with a value of $88 Million.
Latest Holdings of David R. Liu
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRME | Prime Medicine Inc | 2025-06-30 | 20,240,945 | 4.35 | 88,048,111 |
Holding Weightings of David R. Liu
David R. Liu Form 4 Trading Tracker
According to the SEC Form 4 filings, David R. Liu has made a total of 4 transactions in Prime Medicine Inc (PRME) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Prime Medicine Inc is the acquisition of 21,000 shares on June 30, 2025, which cost David R. Liu around $52,920.
Insider Trading History of David R. Liu
- 1
David R. Liu Trading Performance
GuruFocus tracks the stock performance after each of David R. Liu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R. Liu is %. GuruFocus also compares David R. Liu's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R. Liu within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David R. Liu's insider trading performs compared to the benchmark.
Performance of David R. Liu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 209.61 |  | | | | |
| Relative Return to S&P 500(%) | 205.41 | | | | | |
David R. Liu Ownership Network
Ownership Network List of David R. Liu
Ownership Network Relation of David R. Liu
David R. Liu Owned Company Details
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
David R. Liu is the 10 percent owner of Editas Medicine Inc. Other key executives at Editas Medicine Inc include EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly , director & CEO Gilmore Neil O'neill , and EVP & CHIEF FINANCIAL OFFICER Erick Lucera .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, David R. Liu made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 125,012 shares made by Gilmore Neil O'neill , a net sale of 28,516 shares made by Baisong Mei , and a net sale of 15,503 shares made by Linda Burkly .
In summary, during the past 3 months, insiders sold 16,364 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 16,364 shares. During the past 18 months, 195,923 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 150,923 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
David R. Liu Mailing Address
Above is the net worth, insider trading, and ownership report for David R. Liu. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David R. Liu's mailing address is: Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
